Evidence map›Paper›PMID 32365187›Full record

ArticleNucleic acids research2020

Human REXO2 controls short mitochondrial RNAs generated by mtRNA processing and decay machinery to prevent accumulation of double-stranded RNA.

Maciej Szewczyk, Deepshikha Malik, Lukasz S Borowski, Sylwia D Czarnomska, Anna V Kotrys, Kamila Klosowska-Kosicka, Marcin Nowotny, Roman J Szczesny

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maciej SzewczykInstitute of Biochemistry and Biophysics Polish Academy of Sciences, Warsaw 02-106, Poland.
Deepshikha MalikLaboratory of Protein Structure, International Institute of Molecular and Cell Biology, Warsaw 02-109, Poland.
Lukasz S BorowskiInstitute of Biochemistry and Biophysics Polish Academy of Sciences, Warsaw 02-106, Poland.
Sylwia D CzarnomskaInstitute of Biochemistry and Biophysics Polish Academy of Sciences, Warsaw 02-106, Poland.
Anna V KotrysInstitute of Biochemistry and Biophysics Polish Academy of Sciences, Warsaw 02-106, Poland.
Kamila Klosowska-KosickaInstitute of Biochemistry and Biophysics Polish Academy of Sciences, Warsaw 02-106, Poland.
Marcin NowotnyLaboratory of Protein Structure, International Institute of Molecular and Cell Biology, Warsaw 02-109, Poland.
Roman J SzczesnyInstitute of Biochemistry and Biophysics Polish Academy of Sciences, Warsaw 02-106, Poland.
Institute of Biochemistry and Biophysics, Polish Academy of Sciences · PLInternational Institute of Molecular and Cell Biology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA decay is a key element of mitochondrial RNA metabolism. To date, the only well-documented machinery that plays a role in mtRNA decay in humans is the complex of polynucleotide phosphorylase (PNPase) and SUV3 helicase, forming the degradosome. REXO2, a homolog of prokaryotic oligoribonucleases present in humans both in mitochondria and the cytoplasm, was earlier shown to be crucial for maintaining mitochondrial homeostasis, but its function in mitochondria has not been fully elucidated. In the present study, we created a cellular model that enables the clear dissection of mitochondrial and non-mitochondrial functions of human REXO2. We identified a novel mitochondrial short RNA, referred to as ncH2, that massively accumulated upon REXO2 silencing. ncH2 degradation occurred independently of the mitochondrial degradosome, strongly supporting the hypothesis that ncH2 is a primary substrate of REXO2. We also investigated the global impact of REXO2 depletion on mtRNA, revealing the importance of the protein for maintaining low steady-state levels of mitochondrial antisense transcripts and double-stranded RNA. Our detailed biochemical and structural studies provide evidence of sequence specificity of the REXO2 oligoribonuclease. We postulate that REXO2 plays dual roles in human mitochondria, 'scavenging' nanoRNAs that are produced by the degradosome and clearing short RNAs that are generated by RNA processing.

Indexed as

RNA Processing, Post-TranscriptionalRNA Stability14-3-3 ProteinsBiomarkers, TumorExoribonucleasesHeLa CellsHumansMitochondriaProtein MultimerizationRNA, Double-StrandedRNA, MitochondrialSubstrate Specificity14-3-3 ProteinsBiomarkers, TumorExoribonucleasesRNA, Double-StrandedRNA, MitochondrialSFN protein, human

Identifiers

PMID32365187
PMCPMC7261184
OpenAlexW3022790722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.